Paracelsus Medizinische Privatuniversität

University / College


Location: Salzburg, Austria (AT) AT

ISNI: 0000000405235263

ROR: https://ror.org/03z3mg085

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort (2023) Jansen MP, Roemer F, Marijnissen AKC, Kloppenburg M, Blanco FJ, Haugen IK, Berenbaum F, et al. Journal article LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence (2022) Konopa A, Meier M, Franz M, Bernardinelli E, Vögele AL, Atreya R, Ribback S, et al. Journal article Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry (2022) Hanschmann T, Francuzik W, Doelle-Bierke S, Hofmeier KS, Grabenhenrich L, Rueff F, Renaudin JM, et al. Journal article Real-world outcomes using PD-1 antibodies and BRAF plus MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland (2022) Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akcetin L, et al. Journal article Clinical implementation of RNA sequencing for Mendelian disease diagnostics (2022) Yépez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, Ban R, et al. Journal article Registry Data Indicate a Meaningful Chance for Successful Pregnancies after Allogeneic Stem Cell Transplantation: Results from the German Stem Cell Transplant Registry (DRST) (2022) Sockel K, Frank S, Neu A, Ditschkowski M, Hilgendorf I, Goeckenjan M, Stoelzel F, et al. Conference contribution Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial (2022) Roellig C, Steffen B, Schliemann C, Mikesch JH, Alakel N, Herbst R, Haenel M, et al. Conference contribution In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial (2022) Stelljes M, Middeke JM, Bug G, Wagner EM, Mueller LP, Christoph S, Krause S, et al. Conference contribution Cardiac screening prior to return to play after SARS-CoV-2 infection: focus on the child and adolescent athlete: A Clinical Consensus Statement of the Task Force for Childhood Health of the European Association of Preventive Cardiology (2022) D'Ascenzi F, Castelletti S, Adami PE, Cavarretta E, Sanz-De La Garza M, Maestrini V, Biffi A, et al. Journal article Thrombospondin-2 and LDH: potential predictive biomarkers for the treatment of metastatic renal cell carcinoma with everolimus after one VEGF-targeted therapy (MARC-2 study) (2022) Zeuschner P, Hoelters S, Stoeckle M, Seliger B, Mueller A, Bachmann HS, Gruenwald V, et al. Conference contribution